These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19585173)

  • 1. Complete response of an initially non-surgical adenocarcinoma of the duodenum to chemotherapy with the FOLFOX 4 regimen.
    Manfredi S; Thiebot T; Henno S; Falize L; Bretagne JF; Meunier B
    J Gastrointest Surg; 2009 Dec; 13(12):2309-13. PubMed ID: 19585173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical Resection and Adjuvant Chemotherapy with FOLFOX6 for Primary Duodenal Adenocarcinoma and Nodal Metastasis Resulted in Complete Remission].
    Imamura Y; Sasaki M; Kouyama M; Tazaki T; Sugiyama Y; Nakamura H; Kuroo Y; Nakamitsu A; Daimaru Y; Yabuta Y; Shirai A; Uzuhashi K
    Gan To Kagaku Ryoho; 2016 May; 43(5):629-31. PubMed ID: 27210097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma.
    Catania C; Pelosi G; Fazio N; Biffi R; Spitaleri G; Noberasco C; Zampino MG; Maggioni A; Trifirò G; Toffalorio F; Vigna PD; De Braud F; De Pas T
    Acta Oncol; 2010; 49(1):120-1. PubMed ID: 20100147
    [No Abstract]   [Full Text] [Related]  

  • 4. [mFOLFOX6 chemotherapy enabling curative resection in a patient with locally advanced duodenal adenocarcinoma and lymph node metastases].
    Sasaki H; Kaneto H; Iida T; Naganawa Y; Satoh S; Shimizu H; Sasaki K; Konishi Y; Kon S
    Nihon Shokakibyo Gakkai Zasshi; 2015 Dec; 112(12):2135-43. PubMed ID: 26638785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma.
    Xiang XJ; Liu YW; Zhang L; Qiu F; Yu F; Zhan ZY; Feng M; Yan J; Zhao JG; Xiong JP
    Anticancer Drugs; 2012 Jun; 23(5):561-6. PubMed ID: 22481063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case report of FOLFOX treatment for primary duodenal carcinoma with multiple liver metastases].
    Fujiwara Y; Naomoto Y; Tanabe S; Sakurama K; Noma K; Nishikawa T; Motoki T; Takaoka M; Shirakawa Y; Yamatsuji T; Matsuoka J; Tanaka N
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):655-7. PubMed ID: 19381042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiorgan failure in a patient treated with the 5-fluorouracil, leucovorin, oxaliplatin, and irinotecan regimen.
    Schwartzman AD; Sethi R; Smith R
    Clin Colorectal Cancer; 2013 Jun; 12(2):136-9. PubMed ID: 23098664
    [No Abstract]   [Full Text] [Related]  

  • 8. Neoadjuvant Treatment With Trastuzumab and FOLFOX Induces a Complete Pathologic Response in a Metastatic
    Hamad A; Singhi AD; Bahary N; McGrath K; Amarin R; Zeh HJ; Zureikat AH
    J Natl Compr Canc Netw; 2017 Aug; 15(8):983-988. PubMed ID: 28784859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of 119 small bowel adenocarcinoma in Chinese patients.
    Guo XC; Mao ZY; Su D; Wang LJ; Zhang TT; Bai L
    Cancer Invest; 2014 Jun; 32(5):178-83. PubMed ID: 24654694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the FOLFOX/CAPOX regimen for advanced small bowel adenocarcinoma: a three-center study from China.
    Zhang L; Wang LY; Deng YM; Wang FH; Feng F; Chen YC; An X; Chen C; Xu RH; Li YH
    J BUON; 2011; 16(4):689-96. PubMed ID: 22331723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case report of advanced rectal cancer showing a pathological complete response by neo-adjuvant FOLFOX chemotherapy].
    Murata A; Inoue T; Maeda K; Noda E; Nagahara H; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2623-5. PubMed ID: 21224659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FOLFOX regimen in the patients with locally advanced or metastatic gastric cancer].
    Yan D; Dai H
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):217-9. PubMed ID: 19615264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin/5-fluorouracil/leucovorin (FOLFOX4) regimen as an adjuvant chemotherapy in the treatment of advanced jejunal adenocarcinoma: a report of 2 cases.
    Chen CW; Wang WM; Su YC; Wu JY; Hsieh JS; Wang JY
    Med Princ Pract; 2008; 17(6):496-9. PubMed ID: 18836281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective study.
    Mary F; Zaanan A; Boige V; Artru P; Samalin E; Coriat R; Bachet JB; Boubaya M; Benallaoua M; Tougeron D; Afchain P; Locher C; Baumgaertner I; Lecaille C; des Guetz G; Aparicio T;
    Dig Liver Dis; 2016 Dec; 48(12):1498-1502. PubMed ID: 27623185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer.
    Amini A; Sanati H
    Anticancer Drugs; 2011 Nov; 22(10):1024-6. PubMed ID: 21822120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
    Chang MH; Lee IK; Si Y; Lee KS; Woo IS; Byun JH
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):317-23. PubMed ID: 20972872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresectable gastric cancer with gastric outlet obstruction and distant metastasis responding to intraperitoneal and folfox chemotherapy after palliative laparoscopic gastrojejunostomy: report of a case.
    Park JM; Chi KC
    World J Surg Oncol; 2010 Dec; 8():109. PubMed ID: 21167074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy by FOLFOX for gastric hepatoid adenocarcinoma.
    Velut G; Mary F; Wind P; Aparicio T
    Dig Liver Dis; 2014 Dec; 46(12):1135-6. PubMed ID: 25179158
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic significance of a D-dimer cut-off level of >3 µg/ml in colorectal cancer patients treated with standard chemotherapy plus bevacizumab.
    Mochizuki S; Yoshino T; Kojima T; Fuse N; Ikematsu H; Minashi K; Yano T; Tahara M; Kaneko K; Doi T; Koike K; Ohtsu A
    Jpn J Clin Oncol; 2010 Oct; 40(10):933-7. PubMed ID: 20494948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete response of primary bladder adenocarcinoma with the FOLFOX4 regimen.
    Tatli AM; Uysal M; Goksu SS; Gunduz S; Arslan D; Ozdogan M
    Urol Int; 2015; 94(3):363-5. PubMed ID: 24281125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.